184 related articles for article (PubMed ID: 27801326)
1. [Study of abnormal iron metabolism parameters and iron overload in patients with myelodysplastic syndromes].
Song LL; Zheng QQ; Xiao C; Guo J; Wu D; Su JY; Zhou LY; Chang CK
Zhonghua Xue Ye Xue Za Zhi; 2016 Oct; 37(10):903-907. PubMed ID: 27801326
[TBL] [Abstract][Full Text] [Related]
2. [Detection of Hepcidin in transfusion dependent myelodysplastic syndrome patients and its clinical significance].
Qin Y; Liu H; Ruan S; Cai YF; You XF; Song GQ
Zhonghua Xue Ye Xue Za Zhi; 2011 Nov; 32(11):758-61. PubMed ID: 22339912
[TBL] [Abstract][Full Text] [Related]
3. [Study of iron overload assessment by T2* magnetic resonance imaging in patients with myelodysplastic syndromes].
Song LL; Lu HY; Xiao C; Wu LY; Wu D; Su JY; Zhou LY; Chang CK
Zhonghua Xue Ye Xue Za Zhi; 2019 Mar; 40(3):222-226. PubMed ID: 30929390
[No Abstract] [Full Text] [Related]
4. Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusions.
Cui R; Gale RP; Zhu G; Xu Z; Qin T; Zhang Y; Huang G; Li B; Fang L; Zhang H; Pan L; Hu N; Qu S; Xiao Z
Leuk Res; 2014 May; 38(5):545-50. PubMed ID: 24598841
[TBL] [Abstract][Full Text] [Related]
5. [Study on HFE gene mutations in patients with myelodysplastic syndromes and aplastic anemia].
Nie L; Ai XF; Zheng YZ; Li QH; Yang L; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):223-8. PubMed ID: 19731820
[TBL] [Abstract][Full Text] [Related]
6. Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome.
de Montalembert M; Ribeil JA; Brousse V; Guerci-Bresler A; Stamatoullas A; Vannier JP; Dumesnil C; Lahary A; Touati M; Bouabdallah K; Cavazzana M; Chauzit E; Baptiste A; Lefebvre T; Puy H; Elie C; Karim Z; Ernst O; Rose C
PLoS One; 2017; 12(3):e0172147. PubMed ID: 28257476
[TBL] [Abstract][Full Text] [Related]
7. Impact of iron overload by transfusion on survival and leukemia transformation of myelodysplastic syndromes in a single center of China.
Wang Y; Huang L; Hua Y; Liu H; Jiang H; Wang H; Zhang W; Fu R; Shao Z
Hematology; 2021 Dec; 26(1):874-880. PubMed ID: 34753406
[TBL] [Abstract][Full Text] [Related]
8. [Iron chelation therapy and its influence on the alleviation of EPO resistance in MDS patients].
Zhang Y; Xiao C; Gu SC; Chang CK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1027-32. PubMed ID: 25130822
[TBL] [Abstract][Full Text] [Related]
9. [Effects of iron chelation therapy on allogeneic hematopoietic stem cell transplantation in myelodysplastic syndrome patients with iron overload].
Gu CH; Li CX; Ye L; Liu H; Ma JF; Wang T; Zou Q; Chen J; Chen XC; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2016 Mar; 37(3):189-93. PubMed ID: 27033754
[TBL] [Abstract][Full Text] [Related]
10. Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload.
Nolte F; Höchsmann B; Giagounidis A; Lübbert M; Platzbecker U; Haase D; Lück A; Gattermann N; Taupitz M; Baier M; Leismann O; Junkes A; Schumann C; Hofmann WK; Schrezenmeier H
Ann Hematol; 2013 Jan; 92(2):191-8. PubMed ID: 23073603
[TBL] [Abstract][Full Text] [Related]
11. Treatment of transfusional iron overload in patients with myelodysplastic syndrome or severe anemia: data from multicenter clinical practices.
Raptis A; Duh MS; Wang ST; Dial E; Fanourgiakis I; Fortner B; Paley C; Mody-Patel N; Corral M; Scott J
Transfusion; 2010 Jan; 50(1):190-9. PubMed ID: 19719471
[TBL] [Abstract][Full Text] [Related]
12. Red Blood Cell Transfusion Dependency and Hyperferritinemia Are Associated with Impaired Survival in Patients Diagnosed with Myelodysplastic Syndromes: Results from the First Polish MDS-PALG Registry.
Waszczuk-Gajda A; Mądry K; Machowicz R; Drozd-Sokołowska J; Stella-Hołowiecka B; Mital A; Obara A; Szmigielska-Kapłon A; Sikorska A; Subocz E; Jędrzejczak WW; Dwilewicz-Trojaczek J
Adv Clin Exp Med; 2016; 25(4):633-41. PubMed ID: 27629836
[TBL] [Abstract][Full Text] [Related]
13. Can iron overload in patients with lower-risk myelodysplastic syndromes be reduced using erythropoiesis-stimulating agents?
Tsang E; Leitch HA
Ann Hematol; 2016 Jan; 95(1):73-78. PubMed ID: 26453076
[TBL] [Abstract][Full Text] [Related]
14. Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complications.
Remacha ÁF; Arrizabalaga B; Villegas A; Durán MS; Hermosín L; de Paz R; Garcia M; Diez Campelo M; Sanz G;
Ann Hematol; 2015 May; 94(5):779-87. PubMed ID: 25516455
[TBL] [Abstract][Full Text] [Related]
15. Iron overload in myelodysplastic syndromes (MDS).
Gattermann N
Int J Hematol; 2018 Jan; 107(1):55-63. PubMed ID: 29177643
[TBL] [Abstract][Full Text] [Related]
16. Iron chelation improves ineffective erythropoiesis and iron overload in myelodysplastic syndrome mice.
An W; Feola M; Levy M; Aluri S; Ruiz-Martinez M; Sridharan A; Fibach E; Zhu X; Verma A; Ginzburg Y
Elife; 2023 Dec; 12():. PubMed ID: 38153418
[TBL] [Abstract][Full Text] [Related]
17. Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndrome.
Shenoy N; Vallumsetla N; Rachmilewitz E; Verma A; Ginzburg Y
Blood; 2014 Aug; 124(6):873-81. PubMed ID: 24923296
[TBL] [Abstract][Full Text] [Related]
18. [Myelodysplastic syndromes and iron metabolism].
Kawabata H
Rinsho Ketsueki; 2018; 59(10):2042-2049. PubMed ID: 30305507
[TBL] [Abstract][Full Text] [Related]
19. Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromes.
Delforge M; Selleslag D; Triffet A; Mineur P; Bries G; Graux C; Trullemans F; MacDonald K; Abraham I; Pluymers W; Ravoet C
Ann Hematol; 2011 Jun; 90(6):655-66. PubMed ID: 21318574
[TBL] [Abstract][Full Text] [Related]
20. [Study on abnormal iron metabolism and iron overload in patients with aplastic anemia].
Jin P; Shi J; Li XX; Shao YQ; Nie N; Ge ML; Zhang J; Huang ZD; Huang JB; Zheng YZ
Zhonghua Xue Ye Xue Za Zhi; 2013 Oct; 34(10):877-82. PubMed ID: 24171963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
